This activity is designed to educate pharmacists on current issues in the management of MRSA infection, including current treatment guidelines, prevention, and current pharmacotherapies.
This activity is based on a live program that was presented in Danbury, CT on November 20, 2014.
Participants who received credit for the live program should not claim credit for this web based presentation.
System Requirements for Participants:
Operating system: • Windows XP, Vista or 7 • MAC OS X • Latest Version of Adobe Reader
Browser: • Internet Explorer 8.0 or above • Google Chrome 16.0 or above • Firefox 7.0 or above • Safari 5.0 or above
- Knowledge Based
Requirements for CE Credit
- Complete the pre-test
- Review the content of this activity
- Successfully complete the post-test with a score of 70% or higher
- Complete the activity evaluation
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation is completed.
Pharmacists - Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits will NOT be reported.
This activity is supported by an educational grant from Cubist.
The presenter, Joseph V. Etzel, PharmD, Assistant Dean and Associate Clinical Professor, St. John's University, Jamaica, NY does not have any relevant financial relationships with any commericial interests.
American Health Resources assesses conflict of interest wth its intructors, reviewers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are resolved by American Health Resources for fair balance and scientific objectivity.
Disclosure of Unlabeled UseThis educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. American Health Resources does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of American Health Resources. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity is to educate participants on current issues in the management of MRSA infection, including current treatment guidelines, prevention, and current pharmacotherapies.
- List pathogens most commonly associated with skin and soft tissue infections in the US.
- Discuss how MRSA has emerged as a major contributor to morbidity and mortality as a SSTI pathogen.
- List agents commonly used in the management of skin and soft-tissue infections and discuss their appropriate use.
- Summarize newly published guidelines for the management of skin and soft-tissue infections.
- Develop a care plan for a patient who presents with a soft-tissue infection in the ambulatory setting.
Joseph Etzel, PharmD
Brief Bio : Assistant Dean and Associate Clinical Professor, St. John’s University, Jamaica, NY
Release Date: Nov 20, 2014
Credit Expiration Date: Mar 19, 2018